Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 20 Hydroxyecdysone
2. Beta Ecdysone
3. Beta-ecdysone
4. Crustecdysone
5. Ecdysterone
1. Ecdysterone
2. 5289-74-7
3. Crustecdysone
4. Beta-ecdysone
5. Polypodine A
6. Commisterone
7. Crustecdyson
8. Ecdysteron
9. Isoinokosterone
10. Viticosterone
11. The-7
12. 20-oh Ecdysone
13. Beta-ecdysterone
14. Ekdisten
15. Hydroxyecdysone
16. Polypodine C
17. Ecdysten
18. B-ecdysone
19. (2beta,3beta,5beta,22r)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
20. Insect Moulting Hormone
21. 779a7kpl0y
22. Bio101
23. Chembl224128
24. Chebi:16587
25. 20e
26. 20-e
27. Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2b,3b,5b,22r)-
28. Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2.beta.,3.beta.,5.beta.,22r)-
29. (2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one
30. Beta-ecdisone
31. (2b,3b,5b,22r)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
32. 2beta,3beta,14alpha,20,22r,25-hexahydroxy-5beta-cholest-7-en-6-one
33. Mfcd00036740
34. 2beta,3beta,14alpha,20r,22r,25-hexahydroxy-5beta-cholest-7-en-6-one
35. (+)-ecdysterone
36. Smr000539832
37. Unii-779a7kpl0y
38. Edysterone
39. Ecdystene
40. Sarconeos
41. .beta-ecdysterone
42. Nsc-629484
43. 20-hydroxyecdyson
44. Nsc 629484
45. Polypodin A
46. Polypodin C
47. Brn 1917578
48. B-ecdysone,commisterone
49. 20-hydroxy-a-ecdysone
50. Ai3-44727
51. Schembl22086
52. Mls001164644
53. Mls002207226
54. Bio-101 [who-dd]
55. Dtxsid5040388
56. Gtpl11987
57. 20-hydroxyecdysone [mi]
58. Bio-101
59. Hms2230l09
60. Hy-n6979
61. 2-beta,3-beta,14,20,22,25-hexahydroxy-5-beta-cholet-7-en-6-one
62. 20-hydroxy-.alpha.-ecdysone
63. 20-hydroxyecdysone [who-dd]
64. Bdbm50326777
65. Lmst01010209
66. S2417
67. Akos004120029
68. Zinc238809241
69. Ccg-269554
70. Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2beta,3beta,5beta,22r)-
71. Ac-19603
72. Ac-34796
73. Cs-0007134
74. N1350
75. 20-hydroxyecdysone, >=93% (hplc), Powder
76. 289e747
77. A829299
78. Q423338
79. Q-201054
80. (2beta,3beta,5beta)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
81. 2-beta,3-beta,14,20,22,25-hexahydroxy-5-beta-cholet-7-en-6- One
82. (22r)-2beta,3beta,14alpha,20,22,25-hexahydroxy-5beta-cholest-7-en-6-one
83. (2alpha,3alpha,5alpha,22r)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
84. 5-beta-cholest-7-en-6-one, 2-beta,3-beta,14,20,22,25-hexahydroxy-, (22r)-
85. Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2-beta,3-beta,5-beta,22r)-
86. (2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-((2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-6h-cyclopenta[a]phenanthren-6-one
87. (2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1r,2r)-1,2,5-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one
88. 2,3,14-trihydroxy-10,13-dimethyl-17-(1,2,5-trihydroxy-1,5-dimethyl-hexyl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-6-one
Molecular Weight | 480.6 g/mol |
---|---|
Molecular Formula | C27H44O7 |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 480.30870374 g/mol |
Monoisotopic Mass | 480.30870374 g/mol |
Topological Polar Surface Area | 138 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 869 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A 20 Hydroxyecdysone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 20 Hydroxyecdysone, including repackagers and relabelers. The FDA regulates 20 Hydroxyecdysone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 20 Hydroxyecdysone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 20 Hydroxyecdysone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 20 Hydroxyecdysone supplier is an individual or a company that provides 20 Hydroxyecdysone active pharmaceutical ingredient (API) or 20 Hydroxyecdysone finished formulations upon request. The 20 Hydroxyecdysone suppliers may include 20 Hydroxyecdysone API manufacturers, exporters, distributors and traders.
click here to find a list of 20 Hydroxyecdysone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
20 Hydroxyecdysone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 20 Hydroxyecdysone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 20 Hydroxyecdysone GMP manufacturer or 20 Hydroxyecdysone GMP API supplier for your needs.
A 20 Hydroxyecdysone CoA (Certificate of Analysis) is a formal document that attests to 20 Hydroxyecdysone's compliance with 20 Hydroxyecdysone specifications and serves as a tool for batch-level quality control.
20 Hydroxyecdysone CoA mostly includes findings from lab analyses of a specific batch. For each 20 Hydroxyecdysone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
20 Hydroxyecdysone may be tested according to a variety of international standards, such as European Pharmacopoeia (20 Hydroxyecdysone EP), 20 Hydroxyecdysone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (20 Hydroxyecdysone USP).
LOOKING FOR A SUPPLIER?